Apollomics (APLM) Operating Leases (2020 - 2025)
Apollomics (APLM) posted quarterly Operating Leases of $434000.0 for Q4 2025, down 40.79% year-on-year from $733000.0 in Q4 2024, and down 19.78% on a QoQ basis from $541000.0 in Q2 2025.
Apollomics (APLM) Operating Leases (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Operating Leases for 6 consecutive years, with $434000.0 the latest figure, recorded in Q4 2025.
- Quarterly Operating Leases fell 40.79% year-over-year to $434000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $434000.0 (down 40.79% YoY) and the FY2025 annual result came in at $434000.0, down 40.79% from the prior year.
- Operating Leases declined to $434000.0 in Q4 2025 per APLM's latest filing, from $541000.0 in the prior quarter.
- Over the last five years, Operating Leases for APLM reached as high as $1.0 million in Q4 2021 and fell as low as $267000.0 in Q4 2023.
- A 5-year average of $607375.0 and a median of $556000.0 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases jumped 235.28% — and 2022, when it plunged 63.61%.
- Year by year, Operating Leases stood at $1.0 million in 2021, then tumbled by 63.61% to $377000.0 in 2022, then slipped by 29.18% to $267000.0 in 2023, then soared by 174.53% to $733000.0 in 2024, then slumped by 40.79% to $434000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $434000.0, $541000.0, and $733000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 434,000.00 |
| Jun 30, 2025 | 541,000.00 |
| Dec 31, 2024 | 733,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Dec 31, 2023 | 267,000.00 |
| Dec 31, 2022 | 377,000.00 |
| Jun 30, 2022 | 571,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Dec 31, 2020 | 309,000.00 |